FP7H2020HORIZON
Karolinska Institutet
- Country
- SESweden
- Defence projects
- 0
- Projects, all programmes
- 705
- As coordinator
- 254
- EU contribution (CORDIS)
- EUR 463,574,152
- Active
- 2008 to 2026
Projects
705 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| EMMASERVICEServicing the European Biomedical Research Community: Archiving and Dissemination of Mouse Models of Human Disease | FP7 | 2009 | Participant | EUR 306,008 |
| MCI_AD PIB-PET_FMRIAlterations in Memory Networks in Mild Cognitive Impairment and Alzheimer’s disease: Relating the Impact of Amyloid Burden with PIB-PET on Neuronal Activation as Assessed with fMRI | FP7 | 2009 | Coordinator | EUR 221,370 |
| EMTRAINEuropean Medicines Research Training Network | FP7 | 2009 | Participant | EUR 662,060 |
| TORNADOMolecular Targets Open for Regulation by the gut flora – New Avenues for improved Diet to Optimize European health | FP7 | 2009 | Coordinator | EUR 1,202,896 |
| MAMMAHOGLGRUnderstanding Hedgehog signalling in breast cancer and mammary gland stem cells using tissue specific expression of Gli1 the main effector of the Hedgehog pathway | FP7 | 2009 | Coordinator | EUR 179,224 |
| IMMUNOSWITCHSwitch recombination: a model system for DNA editing and repair in human lymphocytes with relevance for primary immunodeficiency and cancer formation | FP7 | 2009 | Coordinator | EUR 1,888,166 |
| FLAVIOLATargeted delivery of dietary flavanols for optimal human cell function: Effect on cardiovascular health | FP7 | 2009 | Participant | EUR 299,840 |
| ANTIRESDEVThe effects of antibiotic administration on the emergence and persistence of antibiotic-resistant bacteria in humans and on the composition of the indigenous microbiotas at various body sites | FP7 | 2009 | Participant | EUR 575,520 |
| METOXIAMetastatic tumours facilitated by hypoxic tumour micro-environments | FP7 | 2009 | Participant | EUR 775,100 |
| SURESupporting the Use of Research Evidence (SURE) for Policy in African Health Systems | FP7 | 2009 | Participant | EUR 79,490 |
| NEMOTreatment of NEonatal seizures with Medication Off-patent: evaluation of efficacy and safety of bumetanide | FP7 | 2009 | Participant | EUR 164,040 |
| SAGHESafety and Appropriateness of Growth hormone treatments in Europe | FP7 | 2009 | Participant | EUR 418,291 |
| ENNAHEuropean Network on Noise And Health | FP7 | 2009 | Participant | EUR 27,546 |
| NKT IN HERPESThe role of natural killer T cells in the early stages of the herpes simplex virus infection in skin | FP7 | 2009 | Coordinator | EUR 179,589 |
| STEMRENEWALIdentification of a new mechanism of stem cell self-renewal; direct implications on self-repair and tumor initiating cells in the brain | FP7 | 2009 | Coordinator | EUR 2,492,593 |
| QUALMATQuality of maternal and prenatal care: bridging the know-do gap | FP7 | 2009 | Participant | EUR 397,020 |
| SUMMITSUrrogate markers for vascular Micro- and Macrovascular hard endpoints for Innovative diabetes Tools | FP7 | 2009 | Participant | EUR 959,999 |
| TRACK_FASTTraining Requirements And Careers for Knowledge-based Food Science and Technology in Europe | FP7 | 2009 | Participant | EUR 37,505 |
| CHAGASEPINETComparative epidemiology of genetic lineages of Trypanosoma cruzi | FP7 | 2009 | Participant | EUR 210,600 |
| DIGITAL SEQUENCINGMassive Digital sequencing by binary DNA | FP7 | 2009 | Participant | EUR 320,244 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.